John Armitage - Egerton Capital (UK) LLP
Holding/activity history for CME Group (CME)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,182,907 | 3.88 | Add 0.26% | 0.01 | $295.35 | $349,371,582 | SEC |
| 2025 Q4 | 1,179,792 | 3.50 | Reduce 0.42% | 0.01 | $273.08 | $322,177,599 | SEC |
| 2025 Q3 | 1,184,788 | 3.38 | Reduce 22.20% | 0.96 | $270.19 | $320,117,870 | SEC |
| 2025 Q2 | 1,522,936 | 4.31 | Reduce 11.98% | 0.63 | $275.62 | $419,751,620 | SEC |
| 2025 Q1 | 1,730,194 | 5.30 | Add 79.40% | 2.35 | $265.29 | $459,003,166 | SEC |
| 2024 Q4 | 964,421 | 2.59 | Buy | 2.59 | $232.23 | $223,967,489 | SEC |
| 2021 Q2 | 0 | 0.00 | Sell 100.00% | 0.52 | SEC | ||
| 2021 Q1 | 449,800 | 0.52 | Reduce 0.10% | <0.01 | $204.23 | $91,863,000 | SEC |
| 2020 Q4 | 450,249 | 0.50 | Buy | 0.50 | $182.05 | $81,968,000 | SEC |